News|Videos|July 10, 2025
Junevity's Bold Move: Using siRNA to Fight Diabetes and Obesity
Author(s)Christopher Cole
Advertisement
In this quick clip from our BIO 2025 interview with Junevity Co-founder and CEO John Hoekman, PhD, Dr. Hoekman summarizes the potential of siRNA to fight diseases like diabetes and obesity.
Check out the full interview
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Implications of FDA’s New Draft Guidance on Innovative Trial Design for Rare-Disease CGTs
2
New FDA Guidance Utilizes Real-World Data and AI for Postmarket CGT Surveillance
3
White House, Pfizer Reach First MFN Pricing Agreement; Who's Next?
4
The Importance of Innovation in Mission-Critical BioPharma Cold Storage
5
